We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$484B
AUM Growth
+$13.2B
Cap. Flow
-$3.88B
Cap. Flow %
-0.8%
Top 10 Hldgs %
13.39%
Holding
2,630
New
93
Increased
1,078
Reduced
887
Closed
93

Sector Composition

Rank Sector Weight
1 Healthcare 21.05%
2 Consumer Discretionary 13.82%
3 Financials 13.14%
4 Industrials 11.9%
5 Technology 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNCR
1951
DELISTED
Synchronoss Technologies
SNCR
$517K ﹤0.01%
1,211
+200
+20% +$78.8K
HT
1952
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$512K ﹤0.01%
19,800
+3,250
+20% +$87.3K
ARIA
1953
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$511K ﹤0.01%
62,000
+14,500
+31% +$107K
SF
1954
Stifel
SF
$12.8B
$510K ﹤0.01%
20,576
+4,500
+28% +$104K
SMP icon
1955
Standard Motor Products
SMP
$882M
$505K ﹤0.01%
11,950
CHMT
1956
DELISTED
Chemtura Corporation
CHMT
$505K ﹤0.01%
18,500
-809
-4% -$20K
IGTE
1957
DELISTED
IGATE CORPORATION
IGTE
$503K ﹤0.01%
11,800
CCC
1958
DELISTED
Calgon Carbon Corp
CCC
$500K ﹤0.01%
23,733
+641
+3% +$13K
SBRA icon
1959
Sabra Healthcare REIT
SBRA
$5.17B
$498K ﹤0.01%
15,033
MKSI icon
1960
MKS Inc
MKSI
$21.2B
$497K ﹤0.01%
14,713
VSH icon
1961
Vishay Intertechnology
VSH
$5.22B
$497K ﹤0.01%
35,998
OKSB
1962
DELISTED
Southwest Bancorp Inc/OK
OKSB
$496K ﹤0.01%
27,900
+2,600
+10% +$42.9K
AMH icon
1963
American Homes 4 Rent
AMH
$12.4B
$495K ﹤0.01%
29,900
+4,200
+16% +$70.2K
MLI icon
1964
Mueller Industries
MLI
$14.8B
$495K ﹤0.01%
54,800
OSPN icon
1965
OneSpan
OSPN
$604M
$495K ﹤0.01%
23,000
+15,600
+211% +$370K
ALX
1966
Alexander's
ALX
$1.4B
$493K ﹤0.01%
1,080
+100
+10% +$45K
LE icon
1967
Lands' End
LE
$389M
$491K ﹤0.01%
13,690
-35,000
-72% -$1.39M
NGG icon
1968
National Grid
NGG
$81.5B
$491K ﹤0.01%
7,878
ACH
1969
Accendra Health
ACH
$85.4M
$491K ﹤0.01%
14,500
+2,200
+18% +$76.6K
EXCU
1970
DELISTED
Exelon Corporation
EXCU
$491K ﹤0.01%
10,060
-100
-1% -$5.1K
KFY icon
1971
Korn Ferry
KFY
$4.29B
$490K ﹤0.01%
14,900
PRI icon
1972
Primerica
PRI
$9.62B
$490K ﹤0.01%
9,618
-3,235
-25% -$168K
LOCK
1973
DELISTED
LifeLock, Inc.
LOCK
$490K ﹤0.01%
34,700
+3,076
+10% +$43.9K
BAH icon
1974
Booz Allen Hamilton
BAH
$9.39B
$489K ﹤0.01%
+16,900
New +$492K
BGC icon
1975
BGC Group
BGC
$5.17B
$488K ﹤0.01%
80,238

Similar funds

T. Rowe Price Associates's Q1 2015 Portfolio in Review

As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
  • T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
  • T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
  • T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
  • T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
  • T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
  • T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.

Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.